Mark B. McClellan, MPA, MD, PhD, is a Senior Fellow and Director of the Engelberg Center for Healthcare Reform, and Leonard D. Schaeffer Director’s Chair in Health Policy at the Brookings Institution. He is also a former administrator for the Centers for Medicare and Medicaid Services (CMS) and former commissioner of the Food and Drug Administration (FDA). A doctor and economist by training, he is developing and implementing ideas to drive improvements in high-quality, innovative, affordable health care. While at the FDA and CMS, McClellan developed and implemented major reforms in health policy, including the Medicare prescription drug benefit, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care.
McClellan’s professional experience includes: associate professor of economics and of medicine, Stanford University, 1995-2001; administrator, Centers for Medicare and Medicaid Services, 2004-2006; commissioner of Food and Drugs, 2002-2004; member, President’s Council of Economic Advisers and senior director for Health Care, White House, 2001-2002; member, Institute of Medicine, 2003-present. McClellan holds a Ph.D. in economics from the Massachusetts Institute of Technology, an MD from Harvard University-Massachusetts Institute of Technology Division of Health Sciences and Technology, an MPA from Harvard University, and a BA from the University of Texas at Austin.